Verona Pharma plc CEO Sells 495,428.88 in Stock

VRNA Stock  USD 39.26  0.70  1.75%   
About 76 percent of Verona Pharma's investors are selling. The analysis of overall sentiment of trading Verona Pharma PLC stock suggests that a fairly large number of investors are terrified at this time. The current market sentiment, together with Verona Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Verona Pharma PLC stock news signals to limit their universe of possible portfolio assets.
  
Verona Pharma plc CEO David Zaccardelli sold 98,888 shares of Verona Pharma stock in a transaction dated Friday, November 29th. The stock was sold at an average price of 5.01, for a total value of 495,428.88. Following the completion of the transaction, the chief executive officer now owns 15,078,624 shares

Read at thelincolnianonline.com
news
  

Verona Pharma Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Verona Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Verona Pharma Fundamental Analysis

We analyze Verona Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verona Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verona Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Shares Shorted

Number Of Shares Shorted Comparative Analysis

Verona Pharma is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Verona Pharma PLC Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Verona Pharma stock to make a market-neutral strategy. Peer analysis of Verona Pharma could also be used in its relative valuation, which is a method of valuing Verona Pharma by comparing valuation metrics with similar companies.

Peers

Verona Pharma Related Equities

BHCBausch Health   2.24   
0%
61.0%
AMPHAmphastar   2.13   
0%
58.0%
EBSEmergent Biosolutions   1.40   
0%
38.0%
ALVOAlvotech   0.95   
0%
25.0%
CTLTCatalent   0.30   
8.0%
0%
HLNHaleon Plc   0.41   
11.0%
0%
ITCIIntracellular   0.57   
15.0%
0%
TAKTakeda Pharmaceutical   0.81   
22.0%
0%
NBIXNeurocrine Biosciences   1.12   
30.0%
0%
TEVATeva Pharma   3.67   
100.0%
0%

Complementary Tools for Verona Stock analysis

When running Verona Pharma's price analysis, check to measure Verona Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verona Pharma is operating at the current time. Most of Verona Pharma's value examination focuses on studying past and present price action to predict the probability of Verona Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verona Pharma's price. Additionally, you may evaluate how the addition of Verona Pharma to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk